J&J Hid Talc's Risk To Shield Flagship Powder, Pa. Jury Told

By Jeannie O'Sullivan (August 18, 2021, 6:49 PM EDT) -- Johnson & Johnson knew its signature talcum powder carried the risk of cancer but hid the information from consumers for decades in order to protect its flagship product, a Philadelphia jury heard Wednesday during the launch of the city's first talc trial.

An attorney for plaintiff Ellen Kleiner said during opening statements in the Philadelphia Court of Common Pleas that the "law is quite clear" that even though talcum powder is considered a cosmetic and not a drug, a company is responsible for ensuring its safety.

Previewing evidence the three men and 12 women will weigh over the next few weeks,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!